A RANDOMISED CONTROLLED TRIAL (RCT) OF AZITHROMYCIN VERSUS DOXYCYCLINE FOR THE TREATMENT OF RECTAL CHLAMYDIA INFECTION IN MEN.

Grant number: 1124172 | Funding period: 2017 - 2019

Completed

Abstract

Rectal chlamydia is very common among gay men; it can exist for long periods without symptoms leading to ongoing transmission. Azithromycin (1 gram single dose) or 7 days doxycycline (100mg twice daily) are the two recommended treatments globally. But, there is concern about rectal chlamydia treatment with reports of up to 22% failure following azithromycin. We will conduct a randomised trial to compare these treatments for rectal chlamydia and determine which drug works better.